RSS

Crestor

Moody's Investors Service has reduced its outlook from positive to stable for the pharmaceutical industry, according to Yahoo Finance more

News

AstraZeneca’s patent on its anti-cholesterol drug, Crestor, is due to expire in May this year and with that expiration could come a drop in the company’s profits more

News